Skip to main content
    D

    Dyadic International Inc (DYAI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.42
    +0.01 (+2.24%)

    Market Cap: $16.43M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    47%(14/30)
    Avg Surprise
    -41.23%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.04
    Range$-0.06 - $-0.03
    3 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$-0.040.0%
    60d ago$-0.03-33.3%
    30d ago$-0.03-33.3%
    7d ago$-0.03-33.3%
    Current$-0.04
    Revenue Consensus
    $1M
    Range$1M - $2M
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.02
    Range$-0.03 - $-0.01
    2 analysts
    Revenue Consensus
    $3M
    Range$2M - $5M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.02---
    Sep 26EST
    		-$-0.04---
    Jun 26
    Reported Aug 12
    		$-0.06$-0.03-100.00%Miss+0.0%
    Mar 26
    Reported May 13
    		$-0.05$-0.04-25.00%Miss+26.3%
    Dec 25
    Reported Mar 25
    		$-0.04$-0.04-11.03%Miss+13.4%
    Sep 25
    Reported Nov 12
    		$-0.06$-0.04-50.00%Miss-500.0%
    Jun 25
    Reported Aug 13
    		$-0.06$-0.06+0.00%Beat+14.3%
    Mar 25
    Reported May 14
    		$-0.07$0.00N/ABeat+2.7%
    Dec 24
    Reported Mar 26
    		$-0.05$-0.04-25.00%Miss+37.5%
    Sep 24
    Reported Nov 12
    		$-0.01N/A+85.71%Beat+83.3%
    Jun 24
    Reported Aug 13
    		$-0.07$-0.06-16.67%Miss+0.0%
    Mar 24
    Reported May 14
    		$-0.07$-0.07+0.43%Beat-332.3%
    Dec 23
    Reported Mar 28
    		$-0.08$-0.06-33.33%Miss-14.3%
    Sep 23
    Reported Nov 8
    		$-0.06$-0.06+0.00%Beat+0.0%
    Jun 23
    Reported Aug 9
    		$-0.07$-0.05-40.00%Miss+41.7%
    Mar 23
    Reported May 10
    		$0.03$-0.03+200.00%Beat+133.3%
    Dec 22
    Reported Mar 29
    		$-0.07$-0.07+0.00%Beat+53.3%
    Sep 22
    Reported Nov 10
    		$-0.06$-0.09+33.33%Beat+0.0%
    Jun 22
    Reported Aug 10
    		$-0.12$-0.07-71.43%Miss+14.3%
    Mar 22
    Reported May 12
    		$-0.09$-0.14+35.71%Beat+25.0%
    Dec 21
    Reported Mar 29
    		$-0.15$-0.02-650.00%Miss-114.3%
    Sep 21
    Reported Nov 10
    		$-0.06$-0.10+40.00%Beat+33.3%
    Jun 21
    Reported Aug 12
    		$-0.14$-0.09-55.56%Miss-40.0%
    Mar 21
    Reported May 13
    		$-0.12$0.09-233.33%Miss-50.0%
    Dec 20
    Reported Mar 30
    		$-0.07$-0.08+12.50%Beat+0.0%
    Sep 20
    Reported Nov 12
    		$-0.09$-0.07-28.57%Miss-50.0%
    Jun 20
    Reported Aug 13
    		$-0.10$-0.07-42.86%Miss+0.0%
    Mar 20
    Reported May 14
    		$-0.08$-0.02-300.00%Miss+0.0%
    Dec 19
    Reported Mar 30
    		$-0.07$-0.07+0.00%Beat-250.0%
    Sep 19
    Reported Nov 13
    		$-0.06$-0.07+14.29%Beat+0.0%
    Jun 19
    Reported Aug 13
    		$-0.10$-0.07-42.86%Miss-66.7%
    Mar 19
    Reported May 9
    		$-0.08$0.00N/ABeat-14.3%
    Dec 18
    Reported Mar 27
    		$-0.02N/A+66.67%Beat+0.0%
    Sep 18
    Reported Dec 18
    		$-0.06$-0.06+0.00%Beat-20.0%
    Jun 18
    Reported Aug 9
    		$-0.06N/AN/ABeat-20.0%
    Mar 18
    Reported May 10
    		$-0.07N/AN/ABeat-200.0%
    Dec 17
    Reported Mar 27
    		$-0.02N/AN/ABeat+66.7%
    Sep 17
    Reported Nov 9
    		$-0.05N/AN/ABeat-
    Jun 17
    Reported Aug 10
    		$-0.05N/AN/ABeat-
    Mar 17
    Reported May 11
    		$0.07N/AN/ABeat-
    Dec 16
    Reported Mar 15
    		$-0.06N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-1.97EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-200.50%Operating Margin-212.80%
    ROE-2827.00%ROIC-213.18%
    Financial Health
    Debt/Equity-2.11xInterest Coverage-17.13x
    Current Ratio1.65xQuick Ratio1.65x
    Trading Statistics
    Beta0.96Avg Volume163.97K
    52-Week High$1.6052-Week Low$0.34

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.44
    SMA 20$0.43
    SMA 50$0.57
    SMA 200$0.79
    EMA 10$0.43
    EMA 20$0.45
    EMA 50$0.56
    EMA 200$0.77

    MACD

    Line: -0.04Signal: -0.05Hist: 0.01

    ADX

    ADX: 23.1+DI: 19.9-DI: 19.4

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down16.0
    PSAR$0.49

    Bollinger Bands

    Upper Band$0.48
    Lower Band$0.39
    %B Position1939%(Upper)
    Band Width0.33

    RSI (14-Day)

    Neutral
    36.4

    Momentum Oscillators

    Stoch %K18.3
    Stoch %D25.7
    Williams %R-80.6
    ROC (10d)-2.4%
    Momentum-0.01
    CCI (20d)-23.3
    MFI (14d)69.5

    Volatility Measures

    ATR (14d)$0.05(12.1%)
    StdDev (20d)0.02
    Hist Vol66.6%(High)

    Volume Flow

    VWAP$0.43
    OBV-14.4M
    AD Line-12.2M
    CMF (20d)-0.328

    Volume Metrics

    Avg Vol (20d)143.8K
    Vol Ratio3.5x(High)
    VWMA (20d)$0.43

    Pivot Points

    R3$0.44
    R2$0.43
    R1$0.42
    Pivot Point$0.42
    S1$0.40
    S2$0.40
    S3$0.39

    Advanced Oscillators

    TSI-28.94
    Ultimate Osc27.0
    KST-143.86

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$961,138$1.11M$235,716$1.16M$463,449$183,100$817,376$1.96M$385,896$334,617$686,535$397,060
    Cost of Revenue$984,165$791,840$384,608$254,753$613,591$297,658$352,819$395,894$301,956$143,955$350,118$105,869
    Gross Profit$-23,027$319,116$-148,892$909,864$-150,142$-114,558$464,557$1.56M$83,940$190,662$336,417$291,191
    Operating Expenses$2.03M$2.23M$1.38M$2.84M$1.58M$1.89M$1.99M$1.76M$2.13M$2.32M$2.50M$2.01M
    R&D$332,621$476,069$458,436$350,046$629,379$494,979$545,660$460,241$515,629$522,723$852,797$716,351
    SG&A$1.69M$1.76M$1.25M$1.48M$1.44M$1.60M$1.44M$1.30M$1.61M$1.79M$1.65M$1.28M
    Operating Income$-2,054,204$-1,912,284$-1,524,929$-1,925,369$-1,729,068$-2,002,475$-1,530,059$-202,614$-2,042,591$-2,125,558$-2,168,420$-1,720,121
    Interest Income$39,705$57,191$83,033$63,467$49,127$88,458$103,747$127,331$138,471$87,443$96,899$105,862
    Interest Expense$109,385$109,181$114,392$85,934$113,833$113,562$126,233$128,177$141,103$32,458$1.09M$0
    Income Before Tax$-2,123,884$-1,954,683$-1,567,263$-1,976,012$-1,793,774$-2,027,579$-1,550,880$-203,460$-2,045,223$-2,009,596$-4,240,222$-1,614,259
    Income Tax Expense$0$0$0$0$0$0$43,277$0$-2,039,445$-43,277$-2,168,424$-118,462
    Net Income$-2,123,884$-1,954,683$-1,567,263$-1,976,012$-1,793,774$-2,027,579$-1,550,880$-203,460$-2,045,223$-2,009,596$-2,071,797$-1,614,259
    EBITDA$-2,014,499$-1,845,502$-1,434,529$-1,890,078$-1,679,941$-1,902,255$-1,420,073$-75,288$-1,904,120$-1,974,013$-811,857$-1,614,259
    EBIT$-2,014,499$-1,845,502$-1,452,871$-1,861,902$-1,679,941$-1,914,017$-1,424,645$-202,614$-1,904,120$-1,977,138$-2,980,280$-3,402,442
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DYAI

    News

    Dyadic International stock faces two Nasdaq compliance tests

    Dyadic International stock is facing two Nasdaq compliance tests after receiving deficiency notices due to its bid price staying below $1 and its market value of listed securities falling below $35 million for 30...

    AD HOC NEWS•10/7/26•Bearish

    Dyadic International stock faces Nasdaq compliance tests by March 2027

    Dyadic International (DYAI) faces Nasdaq compliance tests requiring a $1.00 bid price and a $35.0 million market value by March 24, 2027. The company's market capitalization was $17.0 million on September 29, 2026...

    AD HOC NEWS•9/30/26•Bearish

    Form 8K Dyadic International Inc For: 25 September

    This article announces the filing of a Form 8K by Dyadic International Inc. for September 25. It appears to be a standard financial news brief indicating a regulatory filing by the company...

    Investing.com India•9/25/26•Neutral

    Dyadic International Faces Nasdaq Listing Compliance Challenges

    Dyadic International (DYAI) has received deficiency notices from Nasdaq because its stock traded below the $1 minimum bid price and its Market Value of Listed Securities fell under the $35 million threshold for 30...

    TipRanks•9/25/26•Bearish

    Dyadic International stock rises 2.5 percent as warrants add risk

    Dyadic International's stock rose 2.5% to USD 0.41 on Nasdaq, despite a new filing registering 3,625,000 shares tied to warrants exercisable at USD 0.84...

    AD HOC NEWS•9/24/26•Neutral

    DYAI Valuation and Fair Value

    P/E
    -2.0x
    Forward P/E
    15.8x
    PEG
    0.0x
    P/B
    -6.4x
    See GNG's fair value

    DYAI Profitability: Margins, ROIC and FCF

    Gross margin
    30.4%
    Operating margin
    -212.8%
    Net margin
    -200.5%
    ROIC
    -213.2%
    ROE
    -2827.0%
    FCF margin
    -213.2%

    DYAI Competitors

    CompanyTicker
    Jasper Therapeutics IncJSPR
    Concord Medical Services HoldingsCCM
    Quantum BioPharma Ltd.QNTM
    Psyence Biomedical Ltd. Common SharesPBM
    Neuphoria Therapeutics IncNEUP
    Cyclerion Therapeutics IncCYCN
    ReWalk Robotics LtdLFWD
    Heart Test Laboratories Inc. Common StockHSCS

    Sector: Healthcare

    DYAI Bull Case vs Bear Case

    Bear case

    • DYAI has a -200.5% net profit margin.
    • DYAI beat EPS estimates in 12.5% of its last 8 reported quarters.
    • DYAI's quarterly revenue changed -0.6% year over year.

    DYAI Earnings: Beat Rate and Next Report

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -17.9%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.04
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About DYAI

    Does DYAI pay dividends?

    Dyadic International Inc (DYAI) does not currently pay a regular dividend.

    What is DYAI's market cap?

    Dyadic International Inc (DYAI) has a market capitalization of $16.43M with a current stock price of $0.42.

    Related stocks

    Sector: Healthcare

    All stocks starting with D

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In